Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mechanistic model for HEK293 viral vector processes and its application in a digital shadow framework.

Bioprocess and biosystems engineering·2026
Same author

Advanced Extractables and Leachables Assessment of Microcarriers Used for Adherent Cell Cultures.

Biotechnology journal·2026
Same author

Production of the High Value Pharmaceutical Target, Human Granulocyte-Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co-Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60.

Plant biotechnology journal·2026
Same author

A simplified co-culture reveals altered cardiotoxic responses to doxorubicin in hPSC-derived cardiomyocytes in the presence of endothelial cells.

Stem cell reports·2026
Same author

Lab-Scale Continuous Biomanufacturing: A Tool for Process Development With Adaptive Strategies for Capture and Virus Inactivation.

Biotechnology and bioengineering·2026
Same author

Viable cell sorting by fluidized bed centrifugation enables novel cultivation strategies.

Frontiers in bioengineering and biotechnology·2025

相关实验视频

Updated: May 13, 2026

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K

多参数过程优化用于高产量AAV2载体生产,使用缩放式多平行生物反应器系统和高通量分析工具.

Nazgul Wagner1, Jonas Austerjost1, Julia Niemann1

  • 1Sartorius Stedim Biotech GmbH, August-Spindler-Straße 11, Göttingen 37079, Germany.

Journal of biotechnology
|December 21, 2025
PubMed
概括

使用生物反应器优化腺相关病毒 (AAV) 生产,揭示了温度变化显著提高功能性AAV产量. 批处理过程的效率增加了两倍,而 perfusion 过程的效率增加了三倍以上,从而提高了整体效率.

关键词:
腺相关病毒的病毒.生物制造 生物制造 生物制造基因治疗的基因疗法高通量分析工具的分析工具.多平行生物反应器系统.

更多相关视频

Author Spotlight: Advancing Gene Therapy with High-Yield AAV Vectors Through HEK293 Suspension Cell Cultivation
08:17

Author Spotlight: Advancing Gene Therapy with High-Yield AAV Vectors Through HEK293 Suspension Cell Cultivation

Published on: April 26, 2024

3.2K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

2.5K

相关实验视频

Last Updated: May 13, 2026

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K
Author Spotlight: Advancing Gene Therapy with High-Yield AAV Vectors Through HEK293 Suspension Cell Cultivation
08:17

Author Spotlight: Advancing Gene Therapy with High-Yield AAV Vectors Through HEK293 Suspension Cell Cultivation

Published on: April 26, 2024

3.2K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

2.5K

科学领域:

  • 生物技术是生物技术.
  • 基因治疗 基因治疗
  • 生物工艺工程 生物工艺工程

背景情况:

  • 腺相关病毒 (AAV) 载体对于基因疗法提供至关重要.
  • 过渡性生产是AAV制造的常见但可变的方法.
  • 优化过程参数对于高效的AAV矢量生产至关重要.

研究的目的:

  • 为了评估腺相关病毒 (AAV) 生产的关键过程参数.
  • 为了比较AAV产量的批量与 perfusion 生物工艺模式.
  • 调查温度变化对AAV生产效率的影响.

主要方法:

  • 利用一个15毫升的多平行缩放式生物反应器系统来评估细胞密度和等离子体DNA度.
  • 采用250毫升生物反应器来比较批量和 perfusion 过程.
  • 研究了温度转移策略以提高AAV产量.
  • 评估生产使用生物层干涉计 (BLI) 进行囊位和Incucyte®用于功能位.

主要成果:

  • 在低细胞密度条件下,在37°C的批处理过程中, perfusion 过程的功能位数比批处理过程低三倍以上.
  • 温度变化使功能性AAV产量在批量中增加了近两倍,在 perfusion 过程中增加了三倍以上.
  • 温度变化改善了功能和体标位的比率,表明化增强.

结论:

  • 优化的生物反应器条件,包括温度变化,显著提高功能性AAV产量.
  • 这项研究表明了优化的AAV生产过程的可扩展性和可重复性.
  • 高通量分析技术可以快速评估AAV生产质量.